Beyond SCZ, dysregulation of PVALB-, SST-, and VIP-expressing interneurons has been implicated in a range of neuropsychiatric and neurodegenerative conditions including bipolar disorder, major depression, autism spectrum disorder, and Alzheimer’s disease (50,68, 69, 70). This evidence concerns the gene VIP and early-onset autosomal dominant Alzheimer disease.